|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.250
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.217
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.179
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.151
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.140
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.116
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.109
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.101
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.098
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.088
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.088
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.083
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.083
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.082
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.082
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.075
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.075
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.072
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.071
|
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.070
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.069
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.068
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.066
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.065
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.062
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.061
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.057
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.057
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.056
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.056
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.056
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.056
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.055
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.055
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.054
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.054
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.052
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.052
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.052
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.052
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.051
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.051
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.050
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.050
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.049
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.049
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.047
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.046
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.046
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.045
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.045
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.044
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.044
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.044
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.044
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.044
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.044
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.044
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.043
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.043
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.043
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.043
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.043
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.043
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.043
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.043
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.043
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.042
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.040
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.040
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.040
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.039
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.039
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.039
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.039
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.039
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.038
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.038
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.038
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.038
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.037
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.037
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.037
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.037
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.037
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.037
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.036
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.036
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.036
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.036
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.036
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.035
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.035
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.035
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.035
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.035
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.035
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.034
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.034
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.034
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.033
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.033
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.033
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.033
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.033
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.033
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.032
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.032
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.032
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.031
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.031
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.031
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.030
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.030
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.030
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.030
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.030
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.029
|
|
|
|
modified amino acid transport
|
GO:0072337 |
5 |
0.029
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.029
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.029
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.029
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.029
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.029
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.028
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.028
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.028
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.027
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.027
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.027
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.027
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.027
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.026
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.026
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.026
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.025
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.025
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.024
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.024
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.024
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.023
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.023
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.023
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.023
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.023
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.022
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.022
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.022
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.022
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.022
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.022
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.022
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.022
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.022
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.022
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.022
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.021
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.021
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.021
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.021
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.021
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.021
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.021
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.021
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.021
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.021
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.021
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.020
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.020
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.020
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.020
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.020
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.020
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.020
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.020
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.020
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.019
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.019
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.019
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.019
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.019
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.019
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.018
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.018
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.018
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.018
|
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.018
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.018
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.018
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.018
|
|
|
|
succinate transmembrane transport
|
GO:0071422 |
1 |
0.018
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.018
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.018
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.018
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.018
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.018
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.018
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.018
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.018
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
metanephric capsule morphogenesis
|
GO:0072265 |
1 |
0.017
|
|
|
|
inflammatory response to wounding
|
GO:0090594 |
4 |
0.017
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.017
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.017
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.017
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.017
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.017
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.017
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.017
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.017
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.017
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.017
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.017
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.017
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.017
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.017
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.017
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.017
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.017
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.017
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.017
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.016
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.016
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.016
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.016
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.016
|
|
|
|
retinal bipolar neuron differentiation
|
GO:0060040 |
5 |
0.016
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.016
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.016
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.016
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.016
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.016
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.016
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.016
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.016
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.016
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.016
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.016
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.016
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.016
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.016
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.016
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.016
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.016
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.015
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.015
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.015
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.015
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.015
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.015
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.015
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.015
|
|
|
|
metanephric capsule development
|
GO:0072213 |
1 |
0.015
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.015
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.015
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.015
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.015
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.015
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.015
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.015
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.015
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.015
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.015
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.015
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.015
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.015
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
negative regulation of detection of glucose
|
GO:2000971 |
1 |
0.015
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.015
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.015
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.015
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.014
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.014
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.014
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.014
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.014
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.014
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.014
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.014
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.014
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.014
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.014
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.014
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.014
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.014
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.014
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.014
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.014
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.014
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.014
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.014
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.014
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.014
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.014
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.014
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.014
|
|
|
|
hypothalamus development
|
GO:0021854 |
16 |
0.014
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.014
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.014
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.014
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.014
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.013
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.013
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.013
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.013
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.013
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.013
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.013
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.013
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.013
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.013
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.013
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.013
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.013
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.013
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.013
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.013
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.013
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.013
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.013
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.013
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.013
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.013
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.013
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.013
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.013
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.013
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.013
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.013
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.013
|
|
|
|
renal capsule formation
|
GO:0072129 |
1 |
0.013
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.013
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.013
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.013
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.012
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.012
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.012
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.012
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.012
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.012
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.012
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.012
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.012
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.012
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.012
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
|
apoptotic process involved in outflow tract morphogenesis
|
GO:0003275 |
2 |
0.012
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.012
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.012
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.012
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.012
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.012
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.012
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.012
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.012
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.012
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.012
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.012
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.012
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.012
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.012
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
|
prostate glandular acinus development
|
GO:0060525 |
12 |
0.012
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.012
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.012
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.012
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.012
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.012
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.012
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|